RxDoctor Payments Data

Kathy Wang, DO

Interventional Pain Medicine · Puyallup, WANPI 1053499608

Payments from drug & device makers

What this record shows

34 manufacturers reported payments, led by Boston Scientific at 33.3% of the total.

$10,988in general payments, 2019–2025

Across 199 payments — averaging $55.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$4K
  • Nevro Corp.$2K
  • Abbott$900
  • Relievant Medsystems, Inc.$690
  • Stryker$666
  • Globus Medical$633
  • plus $3K from 28 others

What the payments were for

  • Travel & lodging$4,52041%
  • Food & beverage$6,46859%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,988 in reported general payments places this provider in the 75th percentile of 30 interventional pain medicine providers in Washington.

See all interventional pain medicine providers in Washington

Medicare billing

Part B allowed, 2024
$156,137
Medicare patients
337
Services billed
6,299

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen67$1,381
Celecoxib21$1,216
Pregabalin39$1,127
Gabapentin65$806
Morphine Sulfate ErMorphine Sulfate45$789
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen31$768
Tramadol Hcl48$430
Oxycodone Hcl38$383
Duloxetine Hcl13$334
Hydromorphone Hcl21$291
Tizanidine Hcl22$250
Buprenorphine Hcl11$244
Mirtazapine11$102
Methadone Hcl13$88

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Puyallup

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →